Healing Belongs at Home – Dr. Charu Dutt Arora’s Powerful TEDx Greenfield Talk
#AsianTalks #HealingBelongsAtHome #DrCharuDuttArora #TEDxGreenfield #TEDxTalk #CompassionInHealthcare #HomeCare #PatientCentricCare #ElderlyCare #PalliativeCare #GeriatricMedicine #ChronicIllnessSupport #HealthcareWithHeart #MedicalEmpathy #DignityInCare #HealthcareReform #IdeasWorthSpreading #SocialImpact #PriyankaBehl #AmeriHealth
Healing Belongs at Home – Dr. Charu Dutt Arora’s Powerful TEDx Greenfield Talk
#TycoonWorld #HealingBelongsAtHome #DrCharuDuttArora #TEDxGreenfield #TEDxTalk #CompassionInHealthcare #HomeCare #PatientCentricCare #ElderlyCare #PalliativeCare #GeriatricMedicine #ChronicIllnessSupport #HealthcareWithHeart #MedicalEmpathy #DignityInCare #HealthcareReform #IdeasWorthSpreading #SocialImpact #PriyankaBehl #AmeriHealth #AsianHospital #HealthcareInnovation
https://tycoonworld.in/healing-belongs-at-home-dr-charu-dutt-aroras-powerful-tedx-greenfield-talk/
'Outcomes of endovascular treatment in nonagenarians with symptomatic peripheral arterial disease' - a Hogrefe #Medicine article on #ScienceOpen:
🔗 https://www.scienceopen.com/document?vid=d29d1fef-b3ae-46c1-804c-57f076ebbe50
#VascularMedicine #GeriatricMedicine #PeripheralArterialDisease
<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d10776790e72"> Summary: Background: To report the clinical outcomes of endovascular therapy in nonagenarians treated for symptomatic peripheral arterial disease (PAD). Patients and methods: This is a retrospective analysis of 81 nonagenarians (mean age 93±2.4 years) treated by endovascular therapy for chronic limb threatening ischemia (CLTI) or claudication between December 2017 and August 2023. The composite of amputation and/or death (amputation-free survival; AFS) was the primary endpoint. Technical success, mortality, major limb amputation, risk for Major Adverse Cardio-Cerebro-vascular Events (MACCE) and re-intervention during follow-up were additionally analysed. Results: Most patients presented with CLTI (n=75, 93%). Popliteal artery interventions were most frequently performed (n=59, 73%), followed by superficial femoral artery (n=57, 70%), tibial (n=49, 61%), aortoiliac (n=11, 14%) and common femoral artery (n=7, 9%) procedures. The technical success rate was 100% and the in-hospital mortality was 1% (n=1). At 24 months the AFS was 23.5%, while the major amputation and mortality rates were 4.9% and 75.3% respectively. In the same period the rate of MACCE was 74.1% and the freedom from re-intervention rate amounted to 85.2% The cox regression analysis revealed a lower AFS among males (HR:1.8, 95% CI: 1.06–3.03, p=0.03) and a higher risk for MACCE in patients on warfarin (HR:3.1, 95% CI:1.26–7.59, p=0.01). Conclusions: Despite the high technical success and the low amputation rates, a very high mortality rate at follow up was observed among nonagenarians undergoing endovascular procedures for PAD. Male gender and Warfarin administration increased the risk for adverse events. </p>
Could Getting Rid of Old Cells Turn Back the Clock on Aging?
Researchers are investigating medicines that selectively kill decrepit cells.
https://arstechnica.com/science/2022/12/could-getting-rid-of-old-cells-turn-back-the-clock-on-aging/
#cellularBiology #aging #scientificresearch #geriatricmedicine
This is a nice breakdown of some differences between traditional Medicare, Medicare Advantage, and Medigap plans. It doesn’t go into what kind of crazy profits are made off of denying care.
#MedMastodon #Medicare #Insurance #MedTwitter #HealthCareCost #MedicareForAll #HealthCareIsAHumanRight #GeriatricMedicine
Asian Talks
Tycoon World
ScienceOpen
۞immµnologẏ۞
Jeff Ushupun 🤷🏻♂️